title: Visceral leishmaniasis among liver transplant recipients: an overview.
authors.affiliation: Liver Unit, Department of Internal Medicine, Hospital Universitari Vall Hebron, Barcelona, Spain.
authors.forename: Isabel
authors.initials: I
authors.lastname: Campos-Varela
authors.forename: Oscar
authors.initials: O
authors.lastname: Len
authors.forename: Lluís
authors.initials: L
authors.lastname: Castells
authors.forename: Natalia
authors.initials: N
authors.lastname: Tallada
authors.forename: Esteban
authors.initials: E
authors.lastname: Ribera
authors.forename: Cristina
authors.initials: C
authors.lastname: Dopazo
authors.forename: Víctor
authors.initials: V
authors.lastname: Vargas
authors.forename: Joan
authors.initials: J
authors.lastname: Gavaldà
authors.forename: Ramón
authors.initials: R
authors.lastname: Charco
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007898:Leishmaniasis, Visceral / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D008107:Liver Diseases / Q000601:surgery*; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged
chemical_list: D000981:Antiprotozoal Agents; D000666:Amphotericin B